COL11A1 and neoplasm: While traditional mechanisms such as drug efflux, target modification, and apoptotic dysregulation are well established, emerging evidence highlights the contribution of extracellular matrix components, particularly COL11A1, in modulating tumor metabolism, apoptosis, and epithelial–mesenchymal transition, thereby promoting resistance and disease progression.